The global crisis of diminishing biological diversity is challenging our current ability to monitor changes in ecosystems.

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

In the fall of 2023, breakthroughs in generative AI had researchers proclaiming a new era for medicine and healthcare. In fall 2023, as excitement grew over generative AI’s role in medical ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. DNA replication is essential to life and ...

Microsoft researchers discovered a "zero-day" vulnerability in biosecurity screening software using AI, allowing for the potential bypass of protections against DNA misuse for creating toxins. While ...

Companies that make DNA for science labs screen out any requests for dangerous bits of genetic material. But a new study ...

Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B round of financing that will be used to expand the company’s DNA synthesis production capacity in the U.S. The San ...

On Tuesday, OpenAI announced Sora 2, its second-generation video-synthesis AI model that can now generate videos in various styles with synchronized dialogue and sound effects, which is a first for ...

BigBear.ai and SoundHound AI are targeting different niches within the artificial intelligence (AI) software market. However, only one is growing at a solid rate, while the other one is struggling to ...